Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Cipla
US Department of Justice
Chinese Patent Office
QuintilesIMS
McKinsey
Medtronic
Teva
Merck
Harvard Business School

Generated: October 18, 2017

DrugPatentWatch Database Preview

SONAZINE Drug Profile

« Back to Dashboard

Which patents cover Sonazine, and when can generic versions of Sonazine launch?

Sonazine is a drug marketed by Sandoz and is included in two NDAs.

The generic ingredient in SONAZINE is chlorpromazine hydrochloride. There are twenty drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the chlorpromazine hydrochloride profile page.

Summary for Tradename: SONAZINE

US Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: see list100
Patent Applications: see list1,777
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SONAZINE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz
SONAZINE
chlorpromazine hydrochloride
SYRUP;ORAL083040-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
SONAZINE
chlorpromazine hydrochloride
CONCENTRATE;ORAL080983-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
SONAZINE
chlorpromazine hydrochloride
CONCENTRATE;ORAL080983-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Harvard Business School
Colorcon
Express Scripts
Queensland Health
Moodys
AstraZeneca
Merck
McKesson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot